Bristol Myers Squibb (BMY)
(Delayed Data from NYSE)
$43.99 USD
+0.29 (0.66%)
Updated May 3, 2024 04:00 PM ET
After-Market: $43.92 -0.07 (-0.16%) 7:10 PM ET
3-Hold of 5 3
B Value B Growth D Momentum B VGM
Brokerage Reports
0 items in cart
Bristol Myers Squibb Company [BMY]
Reports for Purchase
Showing records 141 - 160 ( 437 total )
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Weekly Retail Sales Tracker for Hem. Malignancies
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Comprehensive Technical and Fundamental Analysis for BMY.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Comprehensive Technical and Fundamental Analysis for BMY.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Weekly Retail Sales Tracker for Hem. Malignancies - Week Ended October 23
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Comprehensive Technical and Fundamental Analysis for BMY.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Comprehensive Technical and Fundamental Analysis for BMY.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Comprehensive Technical and Fundamental Analysis for BMY.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Weekly Retail Sales Tracker for Hem. Malignancies - Week Ended September 11
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Weekly Retail Sales Tracker for Hem. Malignancies - Week
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Comprehensive Technical and Fundamental Analysis for BMY.
Provider: Stock Traders Daily
Analyst: Research Department